Renal transplantation is an effective treatment for patients with advanced chronic renal disease, and the kidney is the most frequently transplanted organ. Although high mortality rates are observed in the fi rst year post-transplantation, they are lower than those in patients undergoing dialysis with similar risk factor profi les; thus, transplantation can provide a better quality of life and increase the life expectancy (1) .
Urinary tract infections (UTI) are the most common infection after renal transplantation and are a major cause of morbidity and mortality among transplant recipients. In a prospective study of 133 patients transplanted at a single center and followed for one year, 88 infections occurred in 60 patients, and UTIs were responsible for 46 of these cases (53%) (2) . Another prospective study of 159 patients followed for two years after transplant showed a rate of 1.1 episodes of infection per patient, and UTIs were responsible for 46.6% of these episodes (3) .
Urinary tract infections among transplant recipients are usually caused by gram-negative microorganisms, of which Escherichia coli is the most prevalent. In a retrospective cohort study of 136 kidney transplant recipients, 56 developed UTIs, and the most commonly isolated microorganisms were E. coli (59.1%) and Klebsiella spp. (16.9%) (4) . In another retrospective cohort study of 393 kidney transplant recipients, 221 UTI episodes were reported, and the most commonly reported microorganisms were E. coli (18.4%) and Klebsiella spp. (14.6%) (5) .
The main risk factors for contracting a UTI related to kidney transplantation are urinary bladder catheterization, deceased donor kidney, abnormalities of the native kidney or the allograft (such as vesicoureteral reflux), use of a ureteral stent,
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diabetic neurogenic bladder, rejection episodes, and use of immunosuppressive drugs (6) (7) (8) (9) (10) .
The infections that occur in the hospital tend to be more severe, provoking bacteremia in 10% and allograft infection in 90% of recipients. These infections may be associated with allograft dysfunction and can predispose patients to the development of acute allograft rejection (11) (12) (13) .
The aim of this study was to evaluate the risk factors related to acquisition of UTIs in patients during the fi rst year after renal transplantation.
This study was conducted at the University Hospital of the Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. It was a single-center retrospective cohort study of 99 renal transplanted patients (98 kidneys were obtained from deceased donors) followed during the fi rst year after surgery. Demographic and transplant information and risk factors for UTI were collected from the medical records and the intranet system of the hospital. Renal function was evaluated by measuring plasma creatinine levels one year after kidney transplantation.
A UTI episode was defi ned as the presence of at least one of the following signs or symptoms: fever (> 38°C); suprapubic tenderness; costovertebral angle pain or tenderness; or a positive urine culture of ≥ 10 5 colony-forming units (CFU)/mL with no more than 2 species of microorganisms (14) . UTIs were also diagnosed in patients ≤ 65 years of age with fever (> 38°C), urgency, frequency, dysuria, suprapubic tenderness, costovertebral angle pain or tenderness and at least 1 of the following results: a) positive dipstick for leukocyte esterase and/or nitrite; b) pyuria (urine specimen with ≥ 10 white blood cells (WBC)/mm 3 of unspun urine or > 5 WBC/high-power fi eld of spun urine; or c) microorganisms observed on Gram's stain of unspun urine and a positive urine culture of ≥ 10 3 and <10 5 CFU/ml with no more than 2 species of microorganisms (14) . The absence of infection was defi ned as negative urine cultures or bacterial growth with any number of colonies in the absence of symptoms.
Fresh voiding urine was preferably obtained for culture when feasible. For patients using urinary catheters, urine was aseptically obtained by puncturing the drainage system. The bacterial strains were identifi ed using a semi-automated system (Vitek 2TM), which was also used for evaluating susceptibility to antimicrobial agents, according to the criteria of the Clinical Laboratory Standards Institute (CLSI) (15) .
Laboratory tests and urine cultures were programmed for each patient in a 2-week routine collection during hospital admittance. After discharge, the outpatient evaluation schedule was as follows: weekly for the fi rst month, biweekly for the second month, and monthly beginning 3 months post-surgery. In the outpatient clinic, the urine cultures were performed every time the patient presented with symptoms suggestive of UTI and/or fever of unknown origin, allograft pain or leucocyturia even without symptoms. Loss of allograft was defi ned if the patient was submitted to nephrectomy or presented with allograft dysfunction requiring dialysis.
To analyze possible associations between clinical and demographic characteristics with the occurrence of UTI, we used a two-tailed Fisher's exact test. Means of continuous variables were compared using Wilcoxon's test for unpaired samples. To adjust the analysis for possible confounding factors, we used a logistic regression model that only included variables that presented an association with the occurrence of UTI. This was done by univariate statistical analysis with p ≤ 0.10. The level of signifi cance was set at α = 0.05 for all analyses.
Ninety-nine patients were included in the study. During the fi rst year after renal transplantation, 20 patients lost their grafts, 10 patients were lost to follow up, and 7 patients died. None of the patients died or lost their graft as the direct result of a UTI during the study. Twenty-six (26.2%) patients developed UTIs, ten of which were male and sixteen female. The mean time from the day of transplant surgery to the development of infection was 24 days (ranging from 5 to 102 days). The patients' median age was 50 years (ranging from 19 to 71 years). The median dialytic treatment period prior to transplantation was 48 months (ranging from 2 to 240 months), and 16% of patients showed vesicoureteral refl ux or incomplete bladder emptying. Thirty-one percent of the patients were diabetic prior to transplantation. The cold ischemia median time for the deceased donors was 25 hours (ranging from 6 to 48 hours), and forty-two percent of the patients received thymoglobulin as an induction treatment. The only risk factor identifi ed for UTI in the present study was female sex. The analysis of variables associated with the occurrence of UTI is shown in Table 1 .
During the study, 1,847 urocultures were collected, and 320 (17.3%) tested positive for bacterial growth. Seventeen cultures showed the presence of two microorganisms. Among the positive urine samples, 182 (54.1%) presented less than 100,000 CFU/mL, and 155 (45.9%) presented more than 100,000 CFU/mL. The identifi ed microorganisms are shown in Table 2 . The most frequently isolated microorganism in all urine cultures was Klebsiella pneumoniae (44.5%), followed by E. coli (15.4%). The K. pneumoniae strains were highly resistant to carbapenem antibiotics (20.7%).
Of the 99 patients included in the study, 26 had a diagnosis of UTI according to the previous definition. The most frequently identifi ed microorganisms responsible for UTIs were K. pneumoniae (36%), E. coli (20%), Pseudomonas aeruginosa (16%) and Enterobacter cloacae (8%). The antibiotic susceptibility profi les of the microorganisms are presented in Figure 1 . The K. pneumoniae strains were highly resistant to carbapenem antibiotics (33%). Two urine samples with E. cloacae, one with Enterococcus faecalis, and one with Acinetobacter baumannii showed susceptibility to all tested antibiotics. Burkholderia cepacia was susceptible to ceftazidime, meropenem and sulfamethoxazole/trimethoprim. Candida albicans was susceptible to fl uconazole. The most frequently used antibiotics for UTI treatment in the renal transplant patients were ciprofloxacin (30%), meropenem (26%), cefepime (13%) and amikacin (9%). The two patients with fungal UTIs were treated with fl uconazole, and the patient who presented with a positive uroculture to E. faecalis was treated with ciprofl oxacin.
The incidence of UTIs in the present study was 26.2%, and the only risk factor identifi ed was the female sex. In one prospective cohort multicenter study that enrolled 2,052 renal transplant patients, the incidence of UTIs was 10.04%, and the independent risk factors were age, female sex and the need for dialysis post-transplantation (16) . Another report with 393 renal transplanted patients showed a UTI incidence of 56.23%, and the only associated risk factor was age (5) . One retrospective study with 152 renal transplanted patients showed a UTI incidence of 46.71%, and the associated risk factors were female sex, age less than 45 years old, and treatment with cyclosporine plus azathioprine and prednisolone (17) .
The most frequently isolated microorganisms in the present study were K. pneumoniae and E. coli. In contrast, other studies have shown a predominance of E. coli (29%), followed by Enterococcus spp. (24%) (18) . Souza et al. 2010 reported a predominance of E. coli (37%), Enterobacter spp. (19%) and Klebsiella spp. (11%) (19) , and a multicenter study that included 1,762 urine samples collected from thirty-eight sites in eleven countries showed that the most frequent isolates were E. coli (56.5%) and K. pneumoniae (13.8%) (20) . In another prospective study, the authors followed 295 renal transplant patients up to four weeks post-transplantation and collected 582 urine cultures. Among the isolated bacterial strains (n = 291), the most common were gram-negative bacteria (56.4%), predominantly Serratia marcescens (32.3%), E. cloacae (14.6%) and E. coli (12.2%) (21) . One single-center study that investigated the incidence of infections and their causative pathogens during the fi rst three months after renal transplantation analyzed 174 renal transplanted patients and detected 51 UTI episodes in 43 patients. The most frequent pathogen, as in the present study, was K. pneumoniae, followed by E. faecalis and E. coli (22) .
The antimicrobial susceptibility profile of strains in the present study showed a very worrying fi nding: a high percentage of the K. pneumoniae strains were highly resistant to carbapenem antibiotics. The most frequent pathogens associated with UTIs in this facility have changed in recent years. One study performed at this center from 1995-1996 showed that the most frequent pathogen was S. marcescens, which was susceptible to the majority of antibiotics tested, instead of K. pneumonia, which is more prevalent currently. Furthermore, none of the strains in previous reports showed resistance to carbapenem antibiotics (23) . We speculate that the emergence of these drug-resistant strains is associated with the indiscriminate use of antibiotics as well as the increasing number of more severe cases admitted to the hospital. These drug-resistant strains are widespread globally and represent a challenge to the control and management of infections, especially in patients with solid organ transplantation.
In similar populations in other parts of the world, microorganisms have shown different resistance patterns and even an absence of pathogens resistant to carbapenem antibiotics. Vidal et al. (16) Pseudomonas aeruginosa spp. isolates (16) . Golebiewska et al. (24) showed that the most frequently isolated microorganisms were E. coli, E. faecium, Klebsiella spp. and Proteus spp; ESBL strains were present in 32% of these urine cultures (24) . In another study, the incidence of ESBL strains was 34%, with three cases of multi-resistant strains of Klebsiella spp. and two cases of Pseudomonas spp. (25) . Other authors have identifi ed 26.3% of UTIs to be caused by K. pneumoniae carbapenemase-producing strains in renal transplant patients (26) . One study performed in an Italian teaching hospital over 7 months demonstrated an increase in multi-resistant bacteria strains; in the samples that showed K. pneumoniae, the urinary tract was the most frequent infection site (27) . In 2008, the Centers for Disease Control and Prevention (CDC) published that in 2000, only 1% of K. pneumoniae isolates produced carbapenemases as compared to 8% in 2007 (28) . In 2007, the Brazilian Society of Infectious Disease (SBI), due to an increasing number of Enterobacteriaceae showing multidrug resistance (especially increasing numbers of K. pneumoniae strains showing resistance to carbapenem antibiotics), emphasized that the combination of drugs such as polymyxin (B or E) with carbapenems or aminoglycosides may show better results (29) . Another suggested drug combination was polymyxin (B or E) with tigecycline for blood stream infections (29) .
At least one UTI episode was observed in 26% of renal transplant patients during the fi rst year post-transplantation.
Among the UTI risk factors studied, the only one that was associated with a higher incidence of infection was female sex. There were no deaths associated with UTIs in our study. The most frequently isolated microorganism was K. pneumoniae, with 33% of the strains resistant to carbapenem antibiotics.
